Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments

Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments

Abstract Breast cancer (BC) is the most common cancer occurring in women but also rarely develops in men. Recent advances in early diagnosis and development of targeted therapies have greatly improved the survival rate of BC patients. However, the basal-like BC subtype (BLBC), largely overlapping wi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Iga K. Mieczkowska, Garyfallia Pantelaiou-Prokaki, Evangelos Prokakis, Geske E. Schmidt, Lukas C. Müller-Kirschbaum, Marcel Werner, Madhobi Sen, Taras Velychko, Katharina Jannasch, Christian Dullin, Joanna Napp, Klaus Pantel, Harriet Wikman, Maria Wiese, Christof M. Kramm, Frauke Alves, Florian Wegwitz
Format: article
Langue:EN
Publié: Nature Publishing Group 2021
Sujets:
Cytology
QH573-671
Accès en ligne:https://doaj.org/article/20c0c3f49a9e491b86d9b16315f3a86d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/20c0c3f49a9e491b86d9b16315f3a86d

Documents similaires